These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9737273)

  • 1. Congenital adrenal hyperplasia--a continuum of disorders.
    Hughes IA
    Lancet; 1998 Sep; 352(9130):752-4. PubMed ID: 9737273
    [No Abstract]   [Full Text] [Related]  

  • 2. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Fujieda K; Mukai T
    Nihon Rinsho; 2004 Feb; 62(2):361-7. PubMed ID: 14968546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: molecular analysis of congenital adrenal hyperplasia in a newborn screening program.
    Killeen AA
    Mol Diagn; 2001 Sep; 6(3):189-91. PubMed ID: 11571712
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital adrenal hyperplasia: diagnostic advances.
    Torresani T; Biason-Lauber A
    J Inherit Metab Dis; 2007 Aug; 30(4):563-75. PubMed ID: 17694353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening].
    Soriano Guillén L; Velázquez De Cuellar Paracchi M; Ezquieta B
    Med Clin (Barc); 2011 Mar; 136(7):313-4. PubMed ID: 19766262
    [No Abstract]   [Full Text] [Related]  

  • 6. Congenital adrenal hyperplasia.
    Wedell A
    Clin Biochem; 2011 May; 44(7):505-506. PubMed ID: 22036349
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterozygosis for CYP21A2 mutation considered as 21-hydroxylase deficiency in neonatal screening.
    Soardi FC; Lemos-Marini SH; Coeli FB; Maturana VG; Silva MD; Bernardi RD; Justo GZ; de-Mello MP
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1388-92. PubMed ID: 19169499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology
    Horm Res; 2001; 55(4):201-5. PubMed ID: 11598375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening of congenital adrenal hyperplasia.
    Dulín Iñiguez E; Ezquieta Zubicaray B
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):1-4. PubMed ID: 29241677
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of time in assessing the effectiveness of newborn screening for congenital adrenal hyperplasia.
    Tarini BA
    JAMA Pediatr; 2014 Jun; 168(6):515-6. PubMed ID: 24733500
    [No Abstract]   [Full Text] [Related]  

  • 11. Does newborn screening have 100% sensitivity to detect salt wasting congenital adrenal hyperplasia?-Reply.
    Gidlöf S; Nordenström A
    JAMA Pediatr; 2014 Oct; 168(10):971. PubMed ID: 25285872
    [No Abstract]   [Full Text] [Related]  

  • 12. Does newborn screening have 100% sensitivity to detect salt-wasting congenital adrenal hyperplasia?: A word of caution.
    Grosse SD; Sarafoglou K
    JAMA Pediatr; 2014 Oct; 168(10):970-1. PubMed ID: 25285869
    [No Abstract]   [Full Text] [Related]  

  • 13. [New concepts in virilizing adrenal hyperplasia caused by 21-hydroxylase block].
    Cortínez A; Beas F; Devoto L; Henríquez C
    Rev Chil Pediatr; 1985; 56(3):192-8. PubMed ID: 3879364
    [No Abstract]   [Full Text] [Related]  

  • 14. CYP21A2 gene mutation in South Indian children with congenital adrenal hyperplasia.
    Ganesh R; Suresh N; Janakiraman L; Ravikumar K
    Indian Pediatr; 2015 Aug; 52(8):710-1. PubMed ID: 26388637
    [No Abstract]   [Full Text] [Related]  

  • 15. [Congenital adrenal hyperplasia].
    Bouvattier C; Chatelain P
    Rev Prat; 2008 May; 58(9):990-4. PubMed ID: 18672665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal screening for 21-hydroxylase deficient congenital adrenal hyperplasia--the role of CYP21 analysis.
    Root AW
    J Clin Endocrinol Metab; 1999 May; 84(5):1503-4. PubMed ID: 10323368
    [No Abstract]   [Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia: an update in children.
    Trapp CM; Speiser PW; Oberfield SE
    Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):166-70. PubMed ID: 21494138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital Adrenal Hyperplasia.
    Witchel SF
    J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):520-534. PubMed ID: 28450075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
    Nordenström A; Thilén A; Hagenfeldt L; Larsson A; Wedell A
    J Clin Endocrinol Metab; 1999 May; 84(5):1505-9. PubMed ID: 10323369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP21A2 and CYP11B1 gene analyses in a virilized newborn female with congenital adrenal hyperplasia.
    Llorente Martín E; Dabad Moreno MJ; Ezquieta Zubicaray B
    Med Clin (Barc); 2023 Nov; 161(10):448-449. PubMed ID: 37598052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.